LBT Innovations, an Adelaide-based company specialising in medical technology automation using artificial intelligence, has made progress on their Automated Plate Assessment System (APAS) technology.
LBT announced this week that its joint venture company Clever Culture Systems AG (CCS) has shipped an APAS Independence instrument to a key opinion leader laboratory in Germany, marking the first non-sale shipment of APAS instrument to an operational setting in the northern hemisphere.
APAS is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculation and streaking of the agar plates, APAS streamlines the next stages of the microbiology workflow.
Thousands of agar plates are assessed in busy laboratories every day and currently each one has to be examined by a microbiologist for the presence of bacterial colonies. APAS automatically screens, interprets and sorts these plates, freeing up the bottleneck in lab workflows and microbiologists’ time – and enabling faster time to patient results.
APAS eliminates the need for microbiologists to trawl through a multitude of negative plates, allowing them to attend to significant specimens more quickly– reducing the turnaround time for often-critical results.
The German facility Labor Dr Wisplinghoff in Cologne – the largest clinical laboratory in Germany and one of the largest laboratories in Europe – commissioned its first APAS Independence instrument after the AI technology was extensively reviewed in LBT’s facilities in Adelaide and at St Vincent’s Hospital in Melbourne.
CCS is working with Labor Dr Wisplinghoff to create a European APAS centre of excellence to test automation efficiency and clinical validation, in a similar way to the evaluation completed at St Vincent’s Hospital, Melbourne in November 2017. This collaboration aims to extend the current menu of microbiology applications where APAS can be applied and to investigate innovative ways to streamline workflows through the use of APAS technology.